2025 · 2nd Quarter (Apr 1 - June 30)

FERRING PHARMACEUTICALS, INC.

Filed by FERRING PHARMACEUTICALS, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 18, 2025
Income: Not reported
Expenses: $160,000.00
Registrant: FERRING PHARMACEUTICALS, INC.
Client: FERRING PHARMACEUTICALS, INC.
Filing UUID: ab95c70d-4b6e-4d18-86e4-1a615afffac5
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (no bill) issues related to veteran health care coverage (no bill); issues related to military health care coverage (no bill); issues related to Medicare physician fee schedule and Orphan Cures (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

Literal federal measure citations: H. Con. Res. 14, H.R. 1

TAX · Taxation/Internal Revenue Code

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill); issues related to taxation of foreign businesses (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

Literal federal measure citations: H.R. 1878, H. Con. Res. 14, H.R. 1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.